If you have spent any time reading about gut health, you have probably encountered the idea that microbiome diversity is something you should care about. The pitch usually goes like this: diverse microbiomes are healthy, modern life destroys diversity, and you need to eat more plants or take certain supplements to bring your diversity back up. There is some truth buried in there, but the full picture is a lot more complicated than a single number on a stool test report. The concept of microbiome diversity has been flattened into a wellness talking point, and that flattening hides important nuances that actually matter for understanding your gut.
What does 'microbiome diversity' actually measure?
When researchers talk about microbiome diversity, they are usually referring to one of two categories: alpha diversity and beta diversity. Alpha diversity measures the variety within a single sample, meaning how many different species are present and how evenly distributed they are. Beta diversity compares the composition between samples, asking how different your microbiome is from mine, or how different your microbiome is today versus six months ago.
Even within alpha diversity, there are multiple ways to measure it. The Shannon index accounts for both species richness (how many types are present) and evenness (how balanced the proportions are). The Chao1 estimator focuses specifically on how many species are likely present, including rare ones you might miss with shallow sequencing. The Simpson index emphasizes dominance, asking whether a few species are hogging all the resources or whether the community is more balanced. These metrics do not always agree with each other. A sample could look 'diverse' on one index and 'less diverse' on another depending on the community structure (Lozupone et al., 2012). So when a commercial stool test gives you a single 'diversity score,' that number is a simplification of several possible measurements that each tell a different story.
The association between low diversity and disease
The idea that diversity matters did not come from nowhere. There is real research behind it. Patients with inflammatory bowel disease tend to have lower gut microbial diversity than healthy controls (Manichanh et al., 2006). People with recurrent C. difficile infection, which is one of the clearest examples of microbiome disruption, consistently show reduced diversity before fecal microbiota transplant restores it (van Nood et al., 2013). Obesity, type 2 diabetes, and metabolic syndrome have all been associated with lower microbiome diversity in large cohort studies, including the MetaHIT consortium's work in European populations (Le Chatelier et al., 2013).
These associations are real, but they are associations. The critical question is whether reduced diversity is a cause, a consequence, or simply a bystander that correlates with something else. A person with Crohn's disease has chronic intestinal inflammation that creates a hostile environment for many bacterial species, which naturally reduces diversity. The low diversity may not be causing the Crohn's. The Crohn's may be causing the low diversity. Or both could be driven by a third factor. Sorting out causation from correlation in microbiome research is genuinely difficult, and most of the large studies to date are observational.
When higher diversity is not actually 'better'
Here is where the 'more is better' narrative starts to break down. Not all body sites follow the same rules. In the vaginal microbiome, for example, low diversity is actually the healthy state. A Lactobacillus-dominated vaginal community, which has very low diversity, is associated with lower risk of bacterial vaginosis, sexually transmitted infections, and preterm birth. Bacterial vaginosis is characterized by increased diversity, with a shift away from Lactobacillus toward a mixed community of anaerobes (Ravel et al., 2011). If you applied the 'diversity equals health' logic to the vaginal microbiome, you would get it exactly backwards.
Even in the gut, higher diversity is not universally good. After a course of antibiotics, there is a period where the gut community is disrupted and recovering. During this recovery, you might see a temporary increase in diversity as opportunistic species move in to fill ecological niches. That transient diversity is not a sign of health. It can actually represent instability, where the community is in flux and potentially vulnerable to pathogens. A stable, lower-diversity community that performs its core functions well may be healthier than an unstable, high-diversity community in the middle of ecological upheaval.
âšī¸Think of it like an ecosystem. A mature forest has a specific mix of trees, plants, and animals that work together. After a wildfire, you might count more total species for a while as pioneer plants and opportunists move in, but that temporary diversity does not mean the ecosystem is healthier. It means it is recovering.
Functional capacity matters more than species count
One of the most important concepts in modern microbiome research is functional redundancy. This means that many different bacterial species can perform the same metabolic tasks. The Human Microbiome Project found that while the specific species in healthy people's guts varied enormously from person to person, the metabolic pathways those communities encoded were remarkably consistent (Human Microbiome Project Consortium, 2012). In other words, different communities were doing the same work with different workers.
Turnbaugh et al. (2009) described this as a 'core microbiome' defined not by species but by function, things like fermenting dietary fiber into short-chain fatty acids, synthesizing certain B vitamins, metabolizing bile acids, and training the immune system. Two people could share only 30% of their gut species but share 90% of their gut metabolic functions. This has serious implications for how we think about diversity. If what matters is whether your community can produce butyrate, metabolize bile salts, and maintain mucosal immunity, then the species list is secondary to the functional output.
This is why metagenomic and metatranscriptomic approaches, which measure what genes are present and which are actively being expressed, are increasingly seen as more informative than 16S rRNA sequencing, which mostly identifies species. Knowing you have Faecalibacterium prausnitzii is interesting, but knowing that your community is actively producing butyrate is more clinically relevant.
There is no single 'healthy' microbiome
Across different geographies, diets, and lifestyles, what a 'normal' microbiome looks like varies dramatically. The Hadza hunter-gatherers of Tanzania have gut microbiomes that look nothing like those of urban Americans, with substantially higher diversity, different dominant phyla, and seasonal fluctuations tied to wet and dry season diets (Schnorr et al., 2014). Rural populations in Burkina Faso and Malawi show similar patterns of high diversity and distinct composition compared to Western populations (De Filippo et al., 2010).
Does this mean the Hadza are healthier because of higher diversity? It is tempting to think so, but the question is not that simple. The Hadza face different disease burdens, have different life expectancies, and live in entirely different environments. Their microbiomes are adapted to their diet and lifestyle, just as Western microbiomes are adapted (for better or worse) to ours. Drawing direct health comparisons across such different contexts is scientifically fragile.
Even within a single population, variation is enormous. The Human Microbiome Project sequenced the microbiomes of 242 healthy adults and found that no single bacterial species was universally present in all individuals (Human Microbiome Project Consortium, 2012). There was no 'core' set of species that defined health. This makes it extremely difficult to point to any individual's test result and say with confidence whether their diversity is 'good' or 'bad' without knowing their full context.
What consumer microbiome tests actually tell you (and what they do not)
The direct-to-consumer microbiome testing industry has grown substantially in the past decade, with companies offering to analyze your stool sample and give you personalized dietary recommendations. Most of these tests use 16S rRNA gene sequencing, which identifies bacteria by a specific genetic marker. Some newer services use shotgun metagenomic sequencing, which provides more detailed information about functional genes.
The problem is not the technology. It is the interpretation. A 2023 study by Amos et al. sent identical stool samples to multiple consumer testing companies and received substantially different results, both in species identification and in the dietary recommendations generated from those results. The lack of standardization in sample processing, DNA extraction, sequencing depth, bioinformatic pipelines, and reference databases means that your 'diversity score' from one company may not be comparable to a score from another company, or even to your own score from the same company six months later if they have updated their pipeline.
Beyond the technical variability, there is a conceptual problem. Even if the measurement were perfectly accurate, we do not yet have the evidence base to translate most microbiome findings into specific dietary or supplement recommendations for individuals. The gap between 'this population study found an association between X bacteria and Y health outcome' and 'you, specifically, should eat more Z to increase X' is enormous. Most consumer reports paper over this gap with confident-sounding advice.
What actually helps you understand your gut health
If diversity scores are unreliable and species counts are hard to interpret, what should you actually pay attention to? The honest answer is that, for most people, tracking how you feel and what you eat will tell you more about your gut health than any single test. Symptom patterns, food responses, bowel regularity, and how your digestion changes with stress, medications, or dietary shifts are all useful data points that do not require a sequencing lab.
A tool like GLP1Gut can help you track these patterns over time, giving you a record of how your digestion responds to specific foods, meals, and lifestyle factors. That kind of individualized tracking may be more practically useful than a diversity percentage from a stool test, because it reflects your actual experience rather than a population-level statistical association.
That said, there are evidence-based steps that generally support a well-functioning gut community. Eating a variety of plant foods provides different types of fiber that feed different bacterial populations (Sonnenburg and Sonnenburg, 2014). This is not about chasing a diversity number but about providing substrate for the metabolic functions your community needs to perform. Avoiding unnecessary antibiotics preserves community stability. And giving your gut time to recover after disruptions, whether from illness, medication, or dietary changes, respects the ecological nature of the system.
The bottom line on microbiome diversity
Microbiome diversity is a legitimate scientific concept that has been oversimplified into a wellness metric. The research consistently shows that diversity is context-dependent, varies naturally between healthy people, and is less important than functional output for most practical purposes. Low diversity is associated with some diseases, but the direction of causation is often unclear, and increasing diversity is not a proven treatment for anything.
If someone is selling you a product based on your diversity score, be skeptical. If someone tells you there is one ideal microbiome profile, they are wrong. And if someone says 'more diversity is always better,' they have not read the vaginal microbiome literature. The real science is more nuanced, more interesting, and more honest about what we do not yet know.
Is a higher microbiome diversity score always better?
No. While low diversity is associated with some disease states, higher diversity is not universally better. The vaginal microbiome is healthiest when dominated by a single Lactobacillus species. In the gut, unstable high diversity during recovery from antibiotics can reflect ecological disruption rather than health. Context matters enormously.
Can I increase my microbiome diversity through diet?
Eating a wider variety of plant foods has been shown to modestly increase gut microbial diversity in some studies. However, the clinical significance of that increase is not well established. The bigger benefit may come from providing diverse fibers that support the functional capacity of your existing community, rather than chasing a higher diversity number.
Are consumer microbiome tests worth the money?
For most people, the answer is probably no, at least at current accuracy levels. Inter-provider variability is high, and the evidence base for translating results into personalized recommendations is still thin. If you are curious, they can be interesting, but you should not make major dietary or health decisions based solely on a consumer test result.
What is the difference between alpha and beta diversity?
Alpha diversity measures the variety of species within a single sample, your gut at one point in time. Beta diversity compares the composition between different samples, asking how similar or different your microbiome is compared to someone else's, or to your own at a different time. Both are useful in research but capture different information.